ArticleEmerging microbes & infections2024

Comparative study of virus and lymphocyte distribution with clinical data suggests early high dose immunosuppression as potential key factor for the therapy of patients with BoDV-1 infection.

Yannik Vollmuth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.